Market Place
Sourcing Support
Atai Life Sciences Updates On Beckley Psytech`s ELE-101 Trial For Depression
20 Jun 2024 //
GLOBENEWSWIRE
Enveric Signs $66.5M Term Sheet For Psilocin Mental Health Candidate
14 May 2024 //
BUSINESSWIRE
Phyton Biotech Acquires Controlled Substance Dealers License In Canada
29 Nov 2023 //
PRESS RELEASE
Phyton Biotech announces acquisition of Controlled Substances Dealers License from Health Canada
29 Oct 2023 //
PRESS RELEASE
Terran announces publication of PCT patent application covering active forms of psilocin
24 Feb 2023 //
PR NEWSWIRE
Core One Labs` Subsidiaries Successfully Produce Psilocin for to Psilocybin
12 Aug 2022 //
ACCESSWIRE
Filament Health Begins Dosing in Groundbreaking FDA-Approved Psilocin Trial
07 Jul 2022 //
BUSINESSWIRE
Mindset Pharma Receives NoA for Patent Application Covering Psilocin Derivatives
10 Jun 2022 //
GLOBENEWSWIRE
Lennham bags U.S. Patent Covering Methods of Administering Psilocybin & Psilocin
31 May 2022 //
BUSINESSWIRE
Mydecine Reports Successful Synthesis of Novel Tryptamine
27 Oct 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.